RAB11A

RAB11A, member RAS oncogene family, the group of RAB, member RAS oncogene GTPases

Basic information

Region (hg38): 15:65726054-65891989

Links

ENSG00000103769NCBI:8766OMIM:605570HGNC:9760Uniprot:P62491AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD
  • intellectual disability, autosomal dominant 56 (Strong), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RAB11A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAB11A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
25
clinvar
4
clinvar
29
missense
2
clinvar
27
clinvar
5
clinvar
1
clinvar
35
nonsense
2
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
3
3
1
7
non coding
13
clinvar
2
clinvar
15
Total 0 2 29 43 7

Variants in RAB11A

This is a list of pathogenic ClinVar variants found in the RAB11A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-65729184-C-T not specified Uncertain significance (Feb 08, 2023)2482331
15-65729566-C-T not specified Uncertain significance (Oct 09, 2024)3501008
15-65731663-A-G not specified Uncertain significance (Jan 04, 2022)2269253
15-65731691-G-A not specified Uncertain significance (May 09, 2023)2546063
15-65737776-G-C not specified Uncertain significance (Dec 01, 2022)2330504
15-65737786-A-G not specified Uncertain significance (Feb 07, 2025)3839411
15-65737828-T-C not specified Uncertain significance (Oct 09, 2024)3501012
15-65738742-A-C not specified Uncertain significance (Aug 19, 2024)2289672
15-65741772-C-T not specified Uncertain significance (Jan 10, 2025)3839420
15-65752400-G-T not specified Uncertain significance (Nov 15, 2024)3501014
15-65752402-C-T not specified Uncertain significance (May 06, 2022)2287783
15-65752560-C-T not specified Uncertain significance (Aug 02, 2021)2377629
15-65752576-T-G not specified Uncertain significance (Jan 04, 2022)2269229
15-65756213-C-T not specified Uncertain significance (Jun 16, 2024)3271565
15-65756315-T-C not specified Uncertain significance (Mar 16, 2022)2357396
15-65756428-C-T not specified Uncertain significance (Feb 12, 2025)3839418
15-65756438-T-C not specified Uncertain significance (Dec 17, 2023)3081586
15-65867479-G-C Uncertain significance (-)1050179
15-65869595-C-T Uncertain significance (Feb 18, 2022)1702676
15-65869597-C-A Likely benign (Nov 28, 2022)1530161
15-65869601-G-C Uncertain significance (Jul 25, 2024)3600757
15-65869603-C-G Uncertain significance (Apr 01, 2023)2582155
15-65869614-A-C Uncertain significance (Feb 12, 2024)3369151
15-65869618-C-A Likely benign (Dec 11, 2023)1967385
15-65869618-C-T Likely benign (Nov 10, 2022)1644252

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RAB11Aprotein_codingprotein_codingENST00000261890 5165938
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9920.00849125729011257300.00000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.09271240.2180.000006561411
Missense in Polyphen548.820.10242602
Synonymous-0.3644340.11.070.00000193418
Loss of Function3.50014.30.000.00000107126

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. That Rab regulates endocytic recycling. Acts as a major regulator of membrane delivery during cytokinesis. Together with MYO5B and RAB8A participates in epithelial cell polarization. Together with RAB3IP, RAB8A, the exocyst complex, PARD3, PRKCI, ANXA2, CDC42 and DNMBP promotes transcytosis of PODXL to the apical membrane initiation sites (AMIS), apical surface formation and lumenogenesis. Together with MYO5B participates in CFTR trafficking to the plasma membrane and TF (Transferrin) recycling in nonpolarized cells. Required in a complex with MYO5B and RAB11FIP2 for the transport of NPC1L1 to the plasma membrane. Participates in the sorting and basolateral transport of CDH1 from the Golgi apparatus to the plasma membrane. Regulates the recycling of FCGRT (receptor of Fc region of monomeric Ig G) to basolateral membranes. May also play a role in melanosome transport and release from melanocytes. {ECO:0000269|PubMed:15601896, ECO:0000269|PubMed:15689490, ECO:0000269|PubMed:17462998, ECO:0000269|PubMed:19542231, ECO:0000269|PubMed:20890297, ECO:0000269|PubMed:21282656}.;
Pathway
Endocytosis - Homo sapiens (human);Vasopressin-regulated water reabsorption - Homo sapiens (human);Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);NOTCH-Ncore;VEGFA-VEGFR2 Signaling Pathway;Vesicle-mediated transport;TBC/RABGAPs;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Fibroblast growth factor-1;Rab regulation of trafficking;Thromboxane A2 receptor signaling;Notch signaling pathway;RAB geranylgeranylation;Anchoring of the basal body to the plasma membrane;VxPx cargo-targeting to cilium;Arf6 downstream pathway;IL8- and CXCR2-mediated signaling events;Cargo trafficking to the periciliary membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.260

Intolerance Scores

loftool
0.173
rvis_EVS
-0.05
rvis_percentile_EVS
49.39

Haploinsufficiency Scores

pHI
0.478
hipred
Y
hipred_score
0.749
ghis
0.661

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianLowLowLow
Primary ImmunodeficiencyLowLowLow
CancerLowLowLow

Mouse Genome Informatics

Gene name
Rab11a
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; immune system phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype;

Zebrafish Information Network

Gene name
rab11a
Affected structure
vasculature
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
renal water homeostasis;intracellular protein transport;exocytosis;mitotic metaphase plate congression;positive regulation of epithelial cell migration;regulation of multivesicular body size;positive regulation of G2/M transition of mitotic cell cycle;vesicle-mediated transport;astral microtubule organization;neuron projection development;melanosome transport;regulation of cytokinesis;Rab protein signal transduction;multivesicular body assembly;post-translational protein modification;positive regulation of axon extension;regulation of long-term neuronal synaptic plasticity;plasma membrane to endosome transport;regulation of protein transport;establishment of vesicle localization;regulation of vesicle-mediated transport;establishment of protein localization to organelle;protein localization to plasma membrane;establishment of protein localization to membrane;mitotic spindle assembly;ciliary basal body-plasma membrane docking;neurotransmitter receptor transport, endosome to postsynaptic membrane;vesicle-mediated transport in synapse;positive regulation of protein localization to plasma membrane;exosomal secretion
Cellular component
spindle pole;endosome;multivesicular body;Golgi apparatus;trans-Golgi network;centrosome;microtubule organizing center;kinetochore microtubule;cytosol;transport vesicle;axon;cytoplasmic vesicle membrane;cytoplasmic vesicle;vesicle;cleavage furrow;protein-containing complex;intracellular membrane-bounded organelle;phagocytic vesicle;perinuclear region of cytoplasm;recycling endosome;recycling endosome membrane;extracellular exosome;Schaffer collateral - CA1 synapse;postsynaptic recycling endosome;glutamatergic synapse
Molecular function
GTPase activity;protein binding;GTP binding;microtubule binding;syntaxin binding;myosin V binding